Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Operating Income
4,178.00
3,654.00
3,671.00
2,722.00
2,414.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
4,178.00
3,654.00
3,671.00
2,722.00
2,414.00
Expenditure (Ex Depriciation)
Stock Adjustments
12.00
24.00
-87.00
-30.00
-28.00
Raw Materials Consumed
2,537.00
2,249.00
2,432.00
1,721.00
1,502.00
Power & Fuel Cost
160.00
147.00
110.00
76.00
82.00
Employee Cost
646.00
590.00
507.00
420.00
438.00
Operating Expenses
102.00
112.00
104.00
81.00
66.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
55.00
54.00
51.00
23.00
25.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
434.00
76.00
568.00
139.00
95.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,055.00
3,360.00
3,763.00
2,485.00
2,240.00
Operating Profit (PBDIT) excl Other Income
122.00
293.00
-91.00
237.00
174.00
Other Income
34.00
90.00
22.00
21.00
27.00
Operating Profit (PBDIT)
157.00
384.00
-69.00
258.00
201.00
Interest
50.00
46.00
16.00
6.00
19.00
Profit before Depriciation and Tax
106.00
337.00
-85.00
251.00
181.00
Depreciation
125.00
112.00
94.00
69.00
66.00
Profit Before Taxation & Exceptional Items
-19.00
225.00
-180.00
181.00
114.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-45.00
150.00
-193.00
172.00
113.00
Provision for Tax
-46.00
52.00
57.00
48.00
70.00
Profit After Tax
0.00
98.00
-251.00
123.00
43.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
638.00
557.00
832.00
770.00
836.00
Profit Available for appropriations
634.00
652.00
579.00
894.00
880.00
Appropriations
634.00
652.00
579.00
894.00
880.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
-0.28
6.63
-17.65
949.08
357.03
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -9.16% vs 12.22% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 206.30% vs -152.36% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -16.40% vs 38.99% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 197.31% vs -231.91% in Mar 2024
Compare Profit and Loss Results of Akums Drugs
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
4,178.00
2,108.00
2,070.00
98.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
4,178.00
2,108.00
2,070.00
98.20%
Expenditure (Ex Depriciation)
Stock Adjustments
12.00
27.00
-15.00
-55.56%
Raw Materials Consumed
2,537.00
708.00
1,829.00
258.33%
Power & Fuel Cost
160.00
39.00
121.00
310.26%
Employee Cost
646.00
482.00
164.00
34.02%
Operating Expenses
102.00
157.00
-55.00
-35.03%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
55.00
211.00
-156.00
-73.93%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
434.00
34.00
400.00
1,176.47%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,055.00
1,783.00
2,272.00
127.43%
Operating Profit (PBDIT) excl Other Income
122.00
324.00
-202.00
-62.35%
Other Income
34.00
90.00
-56.00
-62.22%
Operating Profit (PBDIT)
157.00
415.00
-258.00
-62.17%
Interest
50.00
4.00
46.00
1,150.00%
Profit before Depriciation and Tax
106.00
410.00
-304.00
-74.15%
Depreciation
125.00
53.00
72.00
135.85%
Profit Before Taxation & Exceptional Items
-19.00
357.00
-376.00
-105.32%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-45.00
357.00
-402.00
-112.61%
Provision for Tax
-46.00
90.00
-136.00
-151.11%
Profit After Tax
0.00
266.00
-266.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
638.00
1,759.00
-1,121.00
-63.73%
Profit Available for appropriations
634.00
2,025.00
-1,391.00
-68.69%
Appropriations
634.00
2,025.00
-1,391.00
-68.69%
Equity Dividend (%)
0%
500%
-500.00
Earnings Per Share
-0.28
16.39
-16.67
-101.71%
Profit And Loss - Net Sales
Net Sales 1,311.78 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -9.16% vs 12.22% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 134.63 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 206.30% vs -152.36% in Mar 2024
Profit And Loss - Interest
Interest 15.31 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -16.40% vs 38.99% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 161.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 197.31% vs -231.91% in Mar 2024






